I recommended our paid members sell their Aurora Cannabis (NYSE: ACB) and Elixinol Global (OTC: ELLXF) holdings. I am no longer confident in either company’s ability to weather a sustained downturn.
Elixinol is facing similar issues, and the company’s U.S. expansion has been a disappointment.
I’m disappointed that these stocks have done so poorly. But I feel it’s best that we cut our losses. It’s possible that these companies will rebound. But I believe they no longer offer an attractive risk-reward proposition.
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.